Handelsbanken Fonder’s AC Immune ACIU Stock Holding History

Handelsbanken Fonder’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-105,000	Closed	-$213K	–	1500
2025 Q2	$213K	Sell	105,000 -25,000	-19%	-$43.5K	﹤0.01%	1485
2025 Q1	$243K	Sell	130,000 -20,000	-13%	-$50.4K	﹤0.01%	1458
2024 Q4	$405K	Hold	150,000	–	–	﹤0.01%	1371
2024 Q3	$567K	Hold	150,000	–	–	﹤0.01%	1196
2024 Q2	$598K	Hold	150,000	–	–	﹤0.01%	1072
2024 Q1	$444K	Buy	150,000 +48,936	+48%	+$175K	﹤0.01%	1212
2023 Q4	$505K	Hold	101,064	–	–	﹤0.01%	1148
2023 Q3	$288K	Hold	101,064	–	–	﹤0.01%	1325
2023 Q2	$299K	Hold	101,064	–	–	﹤0.01%	1350
2023 Q1	$236K	Hold	101,064	–	–	﹤0.01%	1394
2022 Q4	$206K	Hold	101,064	–	–	﹤0.01%	1425
2022 Q3	$319K	Hold	101,064	–	–	﹤0.01%	1218
2022 Q2	$365K	Hold	101,064	–	–	﹤0.01%	1211
2022 Q1	$404K	Buy	+101,064	New	+$438K	﹤0.01%	1345

Other funds holding ACIU

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Handelsbanken Fonder's ACIU Position: Q3 2025 in Review

Handelsbanken Fonder sold out of AC Immune (ACIU) in Q3 2025, closing a stake of 105,000 shares — an estimated $213K sold.

Handelsbanken Fonder first reported a position in ACIU in Q1 2022 and held it in 14 quarters. The position peaked at $598K in Q2 2024. 40 funds tracked by Wall St. Rank hold ACIU as of Q3 2025.

Handelsbanken Fonder reported no remaining AC Immune position as of Q3 2025 after selling out during the quarter.
Handelsbanken Fonder sold 105,000 AC Immune shares in Q3 2025, an estimated $213K.
Handelsbanken Fonder first reported a position in AC Immune in Q1 2022 and held it in 14 quarters.
Handelsbanken Fonder's AC Immune position peaked at $598K in Q2 2024.
40 funds tracked by Wall St. Rank held AC Immune as of Q3 2025.

Based on Handelsbanken Fonder's 13F filing for Q3 2025, filed 12 Nov 2025.